Pulmonary thoracic disorders encompass a wide range of conditions that affect both the lungs and the thoracic structures surrounding them, including the pleura, chest wall, and diaphragm. These disorders can arise from congenital anomalies, infections, trauma, neoplasms, or chronic systemic diseases, leading to impaired respiratory mechanics, reduced lung expansion, and compromised gas exchange. Common manifestations include dyspnea, chest pain, cough, and in severe cases, respiratory failure. Evaluation of pulmonary thoracic disorders relies on a combination of clinical examination, imaging, and functional testing. Chest radiography and computed tomography provide detailed visualization of lung parenchyma, pleural spaces, and thoracic structures, aiding in identifying abnormalities such as effusions, masses, or deformities. Pulmonary function tests measure lung volumes, compliance, and airflow, offering insights into restrictive or obstructive patterns. In selected cases, minimally invasive procedures such as thoracoscopy or biopsy are employed to obtain tissue samples for definitive diagnosis. Management strategies are tailored to the specific disorder and its severity. Therapeutic approaches may include medical management, such as antibiotics or anti-inflammatory agents, interventional procedures like pleural drainage or thoracic surgery, and supportive care, including oxygen therapy and pulmonary rehabilitation. Advances in imaging, minimally invasive surgery, and targeted pharmacologic treatments have improved both diagnostic accuracy and therapeutic outcomes. By integrating precise evaluation, individualized treatment, and supportive care, the management of pulmonary thoracic disorders aims to restore respiratory function, relieve symptoms, and enhance quality of life for patients with complex thoracic and pulmonary conditions.
Title : Screening questionnaires for obstructive sleep apnea: An updated systematic review
Behzad Rahmati, Isfahan University of Medical Sciences, Iran (Islamic Republic of)
Title : Improving covid 19 candidate vaccine response through probiotics and micronutrient supplementation: Evaluating the role of TLR5
Zohre Eftekhari, Biotechnology Research Center, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Iatrogenic pneumothorax following nephrectomy: Case report
Chaimae Tahiri, National University Hospital Center of Fann, Senegal